Faron Pharmaceuticals Oy

FARN.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents£9,503£6,875£6,990£6,853
Short-Term Investments£0£0£0£0
Receivables£201£0£0£0
Inventory£0£0£0£0
Other Curr. Assets£1,361£1,993£2,740£5,170
Total Curr. Assets£11,065£8,868£9,730£12,023
Property Plant & Equip (Net)£298£204£327£207
Goodwill£0£0£0£0
Intangibles£1,113£1,088£1,154£899
Long-Term Investments£0£0£0£0
Tax Assets£0£0£0£0
Other NC Assets£45£60£60£53
Total NC Assets£1,456£1,352£1,541£1,159
Other Assets£0£0£0£0
Total Assets£12,521£10,220£11,271£13,182
Liabilities
Payables£4,876£8,971£6,014£2,229
Short-Term Debt£3,839£3,638£2,004£613
Tax Payable£0£0£0£0
Deferred Revenue£0£0£0£0
Other Curr. Liab.£1,456£2,403£2,453£4,336
Total Curr. Liab.£10,171£15,012£10,471£7,178
LT Debt£8,274£9,473£11,265£2,934
Deferred Rev, NC£0£0£0£151
Deferred Tax Liab, NC£0£0£0£0
Other NC Liab.£3,838£896£1,011£1
Total NC Liab.£12,112£10,369£12,276£3,086
Other Liabilities£0£0£0£0
Cap. Leases£303£213£316£200
Total Liabilities£22,283£25,381£22,747£10,264
Equity
Pref Stock£0£0£0£0
Common Stock£2,691£2,691£2,691£2,691
Retained Earnings-£197,421-£172,208-£143,713-£116,265
AOCI£184,968£154£130£116,493
Other Equity£0£154,202£129,416-£1
Total Equity-£9,762-£15,161-£11,476£2,918
Supplemental Information
Minority Interest£0£0£0£0
Total Liab. & Tot. Equity£12,521£10,220£11,271£13,182
Net Debt£2,610£6,236£6,279-£3,306
Faron Pharmaceuticals Oy (FARN.L) Financial Statements & Key Stats | AlphaPilot